Indegene IPO GMP, Price Range, Details and More

Indegene IPO Will Open On 06 May 2024 and end on 08 May 2024. Indegene IPO Price Range is ₹430-₹452 and Lot Size is 33 shares per lot. The Minimum Bid Price is ₹430 and the Minimum Investment of ₹14,190 For one lot and the Maximum Bid Price Is ₹452 and the maximum investment of ₹14,916 for one lot.

Indegene IPO Issue Size is ₹1841.76 (Cr). Regular Retail Investors can invest up to Rs 2,00,000 and High Networth Individuals can Invest Up to Rs 5,00,000 in Indegene Limited IPO. The allotment date of Indegene Limited IPO is 09th May 2024. Indegene IPO to be listed on May 13 2024.

Indegene IPO Price Range

The Price Range of Indegene Limited IPO is ₹430-₹452.

Indegene IPO GMP

As of 07 May 2024, Indegene IPO GMP is ₹255-₹262. Grey market premium may change depending on market conditions.

Indegene IPO Issue Size

The Issue Size of Indegene IPO is ₹1841.76 (Cr).

Indegene IPO Subscription Status

Particulars	Subscription Rate
Qualified Institutional buyers	0.06x
Non-Institutional Investor	6.20x
Retail Individual Investors	2.12x
Employees	1.88x
Total	2.43x

Indegene IPO Allotment and Listing Date

Shares of Indegene Limited will be allotted to investors on 09th May 2024. Indegene Limited shares are expected to be listed on the NSE and BSE on May 13, 2024.

Indegene IPO Expected Return on Listing Day

Expected Returns On Listing Day of Indegene Limited IPO is 60% and the Price Prediction of Indegene Limited IPO Share Is ₹675-₹688.

Indegene Limited Financials

Revenue: Indegene Limited revenue in 2023 was ₹1005.70(Cr), and in 2022 the revenue was around ₹836.70 (Cr). In 2021 Indegene Limited Revenue is around ₹511.00(Cr).

Profit: Indegene Limited Profits In 2023 were ₹130.20 (Cr) and In 2022 Profit was ₹132.70 (Cr). In 2021 Indegene Limited Profit Is Around ₹132.40(Cr).

Assets Information: The assets of Indegene Limited in 2023 were ₹1037.70 (Cr), and in 2022, the company’s assets were ₹850.10 (Cr). In 2021 Indegene Limited Assets is ₹373.80 (Cr).

About the Indegene Limited

Indegene Limited was Founded in 1998. The headquarters of Indegene Limited is located in Bengaluru, India. Indegene is an emerging company in the healthcare solutions provider and life sciences industry. The company offers assistance in drug development, clinical trials, regulatory submissions, complaint resolution, sales, and marketing. Digital marketing is a core component of Indegene’s offerings, focusing on using technology to increase consumer interaction and brand exposure. As of 2021, Indegene Limited has 4,100 employees. Mr. Manish Gupta is the CEO of Indegene Limited.

Also Read: PFC Share Price Target

FAQ’S